Posted by ABMN Staff on May 4th, 2024
Equities research analysts at StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVO – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the medical research company’s...
More of this article »